久久久国产一区二区_欧美在线小视频_高清一区二区三区_久久综合久久久_成人久久久久久久久_亚洲精品视

上海非利加實業有限公司Logo

熱門詞: 進口電動溫度調節閥結構圖|進口電動溫度調節閥數據表進口電動高溫調節閥-德國進口電動高溫法蘭調節閥進口電動蒸汽調節閥-德國進口電動蒸汽調節閥

當前位置: 首頁 > 所有品牌 > ISCO
ISCO
ISCO ISCO

美國國際干細胞公司 International Stem Cell Corporation


The Company was founded for the specific purposes of solving key problems in the emerging field of regenerative medicine, cell availability and immune rejection. There are growing numbers of cell transplant therapies that have already been demonstrated to be effective in treating major diseases such as diabetes, liver disease and retinal disease, and many others. What is not available is a reliable, renewable and essentially unlimited source of human cells for use in these transplant procedures. Existing embryonic stem cell lines produce cells that will be difficult to match to the patient’s immune system. Parthenogenetic stem cells can solve both of these problems.

ISCO’s goal is to be the universal supplier of therapeutic cells for:

All developing embryonic stem cell based therapeutic procedures.
 

The medical/scientific research community.

To achieve these goals, ISCO has set three objectives:

To create an abundant source of parthenogenetic stem cells to meet the rapidly growing research and therapeutic demands of regenerative medicine and provide those cells to researchers entering clinical trials.
 

To create stem cell lines from unfertilized eggs, which would have all the benefits of human embryonic stem cells, but are superior in their ability to eliminate or diminish immune rejection in patients.
 

To build a true “Cell Bank” using its existing technology that will allow for on-demand delivery of cells that could be matched to the patient’s own immune system and reduce or eliminate the need for immunosuppressant drugs.

ISCO scientists are confident that we have now made the scientific breakthroughs that will meet these objectives. ISCO has created the world’s first human cell lines through the use of parthenogenesis and has already created the parthenogenetic stem cell line that matches the most common immune type in the US population. These parthenote cell lines will, we believe, be critical to open the pathway to successful stem cell therapy.
 

關于我們客戶服務產品分類法律聲明
主站蜘蛛池模板: 免费在线一级毛片 | 欧美精品一区二区三区免费观看 | 一区二区免费在线观看 | 一区二区三区免费在线 | 国产精品99久久久久久www | 欧美日韩一区二区三 | 日韩毛片免费观看 | 国产一区二区三区久久 | 亚洲色图欧美一区 | 国产精品久久久久国产精品 | 国产精品va一区二区三区 | 无遮挡色视频 | 国内一区二区三区精品视频 | 欧美另类色图 | 国产在线观看精品一区二区三区91 | 日韩在线观看一区 | 国产成人精品一区二区三区 | 视频精品一区二区 | 国产高清不卡码一区二区三区 | 美日韩免费视频 | 国产精品高清一区二区三区 | 亚洲欧美影院 | 久久综合中文字幕一区二区 | 国产精品观看 | 国产欧美在线观看一区二区 | 精品一区二区三区五区六区 | 日本欧美一区二区三区不卡视频 | 亚洲韩国日本欧美一区二区三区 | 日韩视频在线观看一区二区 | 日韩精品成人 | 国产日韩一区二区三区在线播放 | 欧美日韩国产在线人 | 欧美 亚洲 中文字幕 | 久久精品成人国产午夜 | 亚洲精美视频 | 国产高清不卡码一区二区三区 | 亚洲国产一成人久久精品 | 成人特黄午夜性a一级毛片 成人国产一区二区三区精品 | 九草在线播放 | 亚洲乱码中文论理电影 | 国产精品久久久久久久久 |